Nuveen’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $65.4M | Sell |
346,148
-35,789
| -9% | -$6.25M | 0.02% | 535 |
|
|
2025
Q4 | $64.9M | Sell |
381,937
-6,764
| -2% | -$1.04M | 0.02% | 533 |
|
|
2025
Q3 | $51.2M | Sell |
388,701
-7,121
| -2% | -$854K | 0.01% | 603 |
|
|
2025
Q2 | $42M | Sell |
395,822
-106,488
| -21% | -$11.6M | 0.01% | 685 |
|
|
2025
Q1 | $62.4M | Buy |
502,310
+33,964
| +7% | +$4.43M | 0.02% | 544 |
|
|
2024
Q4 | $57.7M | Buy |
468,346
+8,448
| +2% | +$996K | 0.02% | 592 |
|
|
2024
Q3 | $51.2M | Buy |
459,898
+41,907
| +10% | +$4.59M | 0.01% | 648 |
|
|
2024
Q2 | $44.6M | Sell |
417,991
-25,540
| -6% | -$2.81M | 0.01% | 676 |
|
|
2024
Q1 | $53.4M | Buy |
443,531
+168,618
| +61% | +$20.7M | 0.02% | 607 |
|
|
2023
Q4 | $33.8M | Buy |
274,913
+38,023
| +16% | +$4.74M | 0.01% | 812 |
|
|
2023
Q3 | $30.7M | Sell |
236,890
-104,393
| -31% | -$13.9M | 0.01% | 788 |
|
|
2023
Q2 | $42.3M | Sell |
341,283
-143,142
| -30% | -$19.3M | 0.01% | 642 |
|
|
2023
Q1 | $70.9M | Buy |
484,425
+8,452
| +2% | +$1.25M | 0.03% | 448 |
|
|
2022
Q4 | $75.8M | Buy |
475,973
+56,810
| +14% | +$8.33M | 0.03% | 422 |
|
|
2022
Q3 | $55.9M | Sell |
419,163
-3,916
| -0.9% | -$595K | 0.02% | 493 |
|
|
2022
Q2 | $66M | Buy |
423,079
+2,635
| +0.6% | +$406K | 0.03% | 461 |
|
|
2022
Q1 | $67.2M | Sell |
420,444
-25,590
| -6% | -$3.71M | 0.02% | 523 |
|
|
2021
Q4 | $56.8M | Sell |
446,034
-3,773
| -0.8% | -$496K | 0.02% | 620 |
|
|
2021
Q3 | $58.6M | Sell |
449,807
-345,349
| -43% | -$52.2M | 0.02% | 611 |
|
|
2021
Q2 | $141M | Buy |
795,156
+43,806
| +6% | +$7.59M | 0.04% | 369 |
|
|
2021
Q1 | $123M | Sell |
751,350
-149,683
| -17% | -$24.6M | 0.04% | 394 |
|
|
2020
Q4 | $149M | Sell |
901,033
-529,948
| -37% | -$78.9M | 0.05% | 338 |
|
|
2020
Q3 | $204M | Sell |
1,430,981
-59,005
| -4% | -$7.32M | 0.08% | 224 |
|
|
2020
Q2 | $164M | Sell |
1,489,986
-145,857
| -9% | -$16.1M | 0.07% | 262 |
|
|
2020
Q1 | $163M | Sell |
1,635,843
-121,445
| -7% | -$15.7M | 0.08% | 219 |
|
|
2019
Q4 | $262M | Sell |
1,757,288
-184,667
| -10% | -$25.1M | 0.1% | 198 |
|
|
2019
Q3 | $249M | Buy |
1,941,955
+17,685
| +0.9% | +$2.37M | 0.1% | 199 |
|
|
2019
Q2 | $274M | Buy |
1,924,270
+1,886,384
| +4,979% | +$254M | 0.11% | 193 |
|
|
2019
Q1 | $5.42M | Buy |
37,886
+26,941
| +246% | +$3.51M | 0.03% | 495 |
|
|
2018
Q4 | $1.36M | Buy |
10,945
+543
| +5% | +$80.6K | 0.01% | 670 |
|
|
2018
Q3 | $1.75M | Buy |
10,402
+885
| +9% | +$152K | 0.01% | 663 |
|
|
2018
Q2 | $1.64M | Buy |
9,517
+1,557
| +20% | +$255K | 0.01% | 646 |
|
|
2018
Q1 | $1.2M | Hold |
7,960
| – | – | 0.01% | 717 |
|
|
2017
Q4 | $1.07M | Hold |
7,960
| – | – | 0.01% | 730 |
|
|
2017
Q3 | $1.16M | Hold |
7,960
| – | – | 0.01% | 723 |
|
|
2017
Q2 | $1.24M | Hold |
7,960
| – | – | 0.01% | 704 |
|
|
2017
Q1 | $1.16M | Sell |
7,960
-705
| -8% | -$91.8K | 0.01% | 906 |
|
|
2016
Q4 | $945K | Buy |
+8,665
| New | +$965K | ﹤0.01% | 1168 |
|
|
2016
Q3 | – | Sell |
-16,060
| Closed | -$2.27M | – | 1423 |
|
|
2016
Q2 | $2.27M | Buy |
16,060
+5,703
| +55% | +$841K | 0.01% | 694 |
|
|
2016
Q1 | $1.35K | Buy |
+10,357
| New | +$1.29M | 0.01% | 907 |
|
|
2015
Q4 | – | Sell |
-104,089
| Closed | -$13.8K | – | 1548 |
|
|
2015
Q3 | $13.8K | Buy |
104,089
+3,213
| +3% | +$553K | 0.08% | 284 |
|
|
2015
Q2 | $17.8K | Sell |
100,876
-3,639
| -3% | -$654K | 0.1% | 271 |
|
|
2015
Q1 | $18.1M | Buy |
104,515
+20,113
| +24% | +$3.45M | 0.1% | 277 |
|
|
2014
Q4 | $13.8M | Sell |
84,402
-62,100
| -42% | -$10.3M | 0.08% | 325 |
|
|
2014
Q3 | $23.5M | Buy |
146,502
+39,305
| +37% | +$6.04M | 0.14% | 190 |
|
|
2014
Q2 | $15.8M | Sell |
107,197
-60,587
| -36% | -$8.4M | 0.1% | 282 |
|
|
2014
Q1 | $23.3M | Sell |
167,784
-5,640
| -3% | -$849K | 0.14% | 195 |
|
|
2013
Q4 | $21.9M | Sell |
173,424
-8,350
| -5% | -$864K | 0.14% | 212 |
|
|
2013
Q3 | $16.7M | Buy |
181,774
+144,928
| +393% | +$11.7M | 0.11% | 248 |
|
|
2013
Q2 | $2.53M | Buy |
+36,846
| New | +$2.25M | 0.02% | 680 |
|
Other funds holding JAZZ
VPM
VCM
EC
Nuveen's JAZZ Position: Q1 2026 in Review
Nuveen reduced its Jazz Pharmaceuticals (JAZZ) stake by 9.4% in Q1 2026, selling an estimated $6.25M and leaving 346,148 shares worth $65.4M. The position accounts for 0.02% of the portfolio, ranked #535.
Nuveen first reported a position in JAZZ in Q2 2013 and has held it in 50 quarters since. The position peaked at $274M in Q2 2019. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Nuveen held 346,148 shares of Jazz Pharmaceuticals worth $65.4M as of Q1 2026.
- Nuveen sold 35,789 Jazz Pharmaceuticals shares in Q1 2026, an estimated $6.25M.
- Jazz Pharmaceuticals made up 0.02% of Nuveen's portfolio in Q1 2026, its #535 holding.
- Nuveen first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
- Nuveen's Jazz Pharmaceuticals position peaked at $274M in Q2 2019.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.